SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-010123
Filing Date
2024-03-29
Accepted
2024-03-29 17:31:12
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K pirs20231231_10k.htm   iXBRL 10-K 1787665
2 EXHIBIT 10.45 ex_646252.htm EX-10.45 23431
3 EXHIBIT 10.46 ex_646253.htm EX-10.46 84913
4 EXHIBIT 10.62 ex_646254.htm EX-10.62 8510
5 EXHIBIT 10.65 ex_646255.htm EX-10.65 56133
6 EXHIBIT 10.66 ex_646256.htm EX-10.66 118855
7 EXHIBIT 10.67 ex_646257.htm EX-10.67 10090
8 EXHIBIT 21.1 ex_599469.htm EX-21.1 3295
9 EXHIBIT 23.1 ex_599470.htm EX-23.1 16244
10 EXHIBIT 31.1 ex_599471.htm EX-31.1 8158
11 EXHIBIT 31.2 ex_599472.htm EX-31.2 8038
12 EXHIBIT 32.1 ex_599473.htm EX-32.1 5315
13 EXHIBIT 32.2 ex_599474.htm EX-32.2 5300
14 EXHIBIT 97 ex_646258.htm EX-97 29985
20 ex_646254img001.jpg GRAPHIC 3223
21 pirs20221231_10kimg001.jpg GRAPHIC 5322
22 pirs20221231_10kimg002.jpg GRAPHIC 7860
  Complete submission text file 0001437749-24-010123.txt   8087118

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA pirs-20231231.xsd EX-101.SCH 65056
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20231231_cal.xml EX-101.CAL 54536
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20231231_def.xml EX-101.DEF 463829
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20231231_lab.xml EX-101.LAB 406061
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20231231_pre.xml EX-101.PRE 495260
93 EXTRACTED XBRL INSTANCE DOCUMENT pirs20231231_10k_htm.xml XML 1031880
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37471 | Film No.: 24804919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)